{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:53:30Z","timestamp":1790481210132,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41589-018-0155-8","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T15:43:46Z","timestamp":1541432626000},"page":"1099-1108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Selective blockade of the lyso-PS lipase ABHD12 stimulates immune responses in vivo"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-4698","authenticated-orcid":false,"given":"Daisuke","family":"Ogasawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taka-Aki","family":"Ichu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent F.","family":"Vartabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Benthuysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya A.","family":"Ulanovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Hulce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Teijaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5330-3492","authenticated-orcid":false,"given":"Benjamin F.","family":"Cravatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"155_CR1","first-page":"1","volume":"378","author":"H Rosen","year":"2014","unstructured":"Rosen, H., Germana Sanna, M., Gonzalez-Cabrera, P. J. & Roberts, E. The organization of the sphingosine 1-phosphate signaling system. Curr. Top. Microbiol. Immunol. 378, 1\u201321 (2014).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"155_CR2","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1194\/jlr.R046458","volume":"55","author":"YC Yung","year":"2014","unstructured":"Yung, Y. C., Stoddard, N. C. & Chun, J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J. Lipid Res. 55, 1192\u20131214 (2014).","journal-title":"J. Lipid Res."},{"key":"155_CR3","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1194\/jlr.R046920","volume":"55","author":"K Makide","year":"2014","unstructured":"Makide, K. et al. Novel lysophosphoplipid receptors: their structure and function. J. Lipid Res. 55, 1986\u20131995 (2014).","journal-title":"J. Lipid Res."},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","volume":"333","author":"Y Kihara","year":"2015","unstructured":"Kihara, Y., Mizuno, H. & Chun, J. Lysophospholipid receptors in drug discovery. Exp. Cell Res. 333, 171\u2013177 (2015).","journal-title":"Exp. Cell Res."},{"key":"155_CR5","doi-asserted-by":"publisher","first-page":"48122","DOI":"10.1074\/jbc.M206941200","volume":"277","author":"D Kleij van der","year":"2002","unstructured":"van der Kleij, D. et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277, 48122\u201348129 (2002).","journal-title":"J. Biol. Chem."},{"key":"155_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.12703\/P6-109","volume":"6","author":"PJ Gonzalez-Cabrera","year":"2014","unstructured":"Gonzalez-Cabrera, P. J., Brown, S., Studer, S. M. & Rosen, H. S1P signaling: new therapies and opportunities. F1000Prime Rep. 6, 109 (2014).","journal-title":"F1000Prime Rep."},{"key":"155_CR7","first-page":"1029","volume":"85","author":"A Inoue","year":"2013","unstructured":"Inoue, A. & Aoki, J. TGFalpha shedding assay is useful for identifying ligands for orphan GPCRs. Seikagaku 85, 1029\u20131033 (2013).","journal-title":"Seikagaku"},{"key":"155_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/jb\/mvs011","volume":"151","author":"H Kitamura","year":"2012","unstructured":"Kitamura, H. et al. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position. J. Biochem. 151, 511\u2013518 (2012).","journal-title":"J. Biochem."},{"key":"155_CR9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1084\/jem.20141827","volume":"212","author":"MJ Barnes","year":"2015","unstructured":"Barnes, M. J. et al. The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function. J. Exp. Med. 212, 1011\u20131020 (2015).","journal-title":"J. Exp. Med."},{"key":"155_CR10","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbrc.2006.01.069","volume":"341","author":"T Sugo","year":"2006","unstructured":"Sugo, T. et al. Identification of a lysophosphatidylserine receptor on mast cells. Biochem. Biophys. Res. Commun. 341, 1078\u20131087 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"155_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bbrc.2017.10.028","volume":"494","author":"Y Shinjo","year":"2017","unstructured":"Shinjo, Y. et al. Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS3\/GPR174. Biochem. Biophys. Res. Commun. 494, 332\u2013338 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"155_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/imcb.12025","volume":"96","author":"MJ Barnes","year":"2018","unstructured":"Barnes, M. J. & Cyster, J. G. Lysophosphatidylserine suppression of T-cell activation via GPR174 requires G\u03b1s proteins. Immunol. Cell Biol. 96, 439\u2013445 (2018).","journal-title":"Immunol. Cell Biol."},{"key":"155_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nchembio.1721","volume":"11","author":"SS Kamat","year":"2015","unstructured":"Kamat, S. S. et al. Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay. Nat. Chem. Biol. 11, 164\u2013171 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"155_CR14","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1074\/jbc.272.4.2192","volume":"272","author":"T Sato","year":"1997","unstructured":"Sato, T. et al. Serine phospholipid-specific phospholipase A that is secreted from activated platelets. A new member of the lipase family. J. Biol. Chem. 272, 2192\u20132198 (1997).","journal-title":"J. Biol. Chem."},{"key":"155_CR15","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1073\/pnas.1217121110","volume":"110","author":"JL Blankman","year":"2013","unstructured":"Blankman, J. L., Long, J. Z., Trauger, S. A., Siuzdak, G. & Cravatt, B. F. ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc. Natl Acad. Sci. USA 110, 1500\u20131505 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"155_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajhg.2010.08.002","volume":"87","author":"T Fiskerstrand","year":"2010","unstructured":"Fiskerstrand, T. et al. Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am. J. Hum. Genet. 87, 410\u2013417 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"155_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1212\/01.wnl.0000333664.90605.23","volume":"72","author":"T Fiskerstrand","year":"2009","unstructured":"Fiskerstrand, T. et al. A novel Refsum-like disorder that maps to chromosome 20. Neurology 72, 20\u201327 (2009).","journal-title":"Neurology"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"e98286","DOI":"10.1371\/journal.pone.0098286","volume":"9","author":"T Parkkari","year":"2014","unstructured":"Parkkari, T. et al. Discovery of triterpenoids as reversible inhibitors of \u03b1\/\u03b2-hydrolase domain containing 12 (ABHD12). PLoS One 9, e98286 (2014).","journal-title":"PLoS One"},{"key":"155_CR19","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1016\/j.bmcl.2008.06.091","volume":"18","author":"HS Hoover","year":"2008","unstructured":"Hoover, H. S., Blankman, J. L., Niessen, S. & Cravatt, B. F. Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg. Med. Chem. Lett. 18, 5838\u20135841 (2008).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"155_CR20","doi-asserted-by":"publisher","first-page":"20941","DOI":"10.1073\/pnas.1011663107","volume":"107","author":"DA Bachovchin","year":"2010","unstructured":"Bachovchin, D.A. et al. Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus library screening. Proc. Natl Acad. Sci. U.S.A. 107, 20941\u201320946 (2010).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"155_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nchembio.579","volume":"7","author":"A Adibekian","year":"2011","unstructured":"Adibekian, A. et al. Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors. Nat. Chem. Biol. 7, 469\u2013478 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"155_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-4939-3539-0_19","volume":"1412","author":"JR Savinainen","year":"2016","unstructured":"Savinainen, J. R., Navia-Paldanius, D. & Laitinen, J. T. A sensitive and versatile fluorescent activity assay for ABHD12. Methods Mol. Biol. 1412, 179\u2013189 (2016).","journal-title":"Methods Mol. Biol."},{"key":"155_CR23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1194\/jlr.D056390","volume":"56","author":"T Wel van der","year":"2015","unstructured":"van der Wel, T. et al. A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase \u03b1. J. Lipid Res. 56, 927\u2013935 (2015).","journal-title":"J. Lipid Res."},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nbt826","volume":"21","author":"D Leung","year":"2003","unstructured":"Leung, D., Hardouin, C., Boger, D. L. & Cravatt, B. F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol. 21, 687\u2013691 (2003).","journal-title":"Nat. Biotechnol."},{"key":"155_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.chembiol.2015.05.018","volume":"22","author":"AB Cognetta III","year":"2015","unstructured":"Cognetta, A. B. III et al. Selective N-hydroxyhydantoin carbamate inhibitors of mammalian serine hydrolases. Chem. Biol. 22, 928\u2013937 (2015).","journal-title":"Chem. Biol."},{"key":"155_CR26","doi-asserted-by":"publisher","first-page":"14694","DOI":"10.1073\/pnas.96.26.14694","volume":"96","author":"Y Liu","year":"1999","unstructured":"Liu, Y. & Patricelli, M. P. & Cravatt, B. F. et al. Activity-based protein profiling: the serine hydrolases.Proc. Natl Acad. Sci. USA 96, 14694\u201314699 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"155_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-11-r130","volume":"10","author":"C Wu","year":"2009","unstructured":"Wu, C. et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130 (2009).","journal-title":"Genome Biol."},{"key":"155_CR28","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"155_CR29","doi-asserted-by":"publisher","first-page":"e12345","DOI":"10.7554\/eLife.12345","volume":"5","author":"A Viader","year":"2016","unstructured":"Viader, A. et al. A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation. eLife 5, e12345 (2016).","journal-title":"eLife"},{"key":"155_CR30","doi-asserted-by":"publisher","first-page":"30235","DOI":"10.1074\/jbc.M806194200","volume":"283","author":"MA Gij\u00f3n","year":"2008","unstructured":"Gij\u00f3n, M. A., Riekhof, W. R., Zarini, S., Murphy, R. C. & Voelker, D. R. Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils. J. Biol. Chem. 283, 30235\u201330245 (2008).","journal-title":"J. Biol. Chem."},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","volume":"14","author":"JL Blankman","year":"2007","unstructured":"Blankman, J. L., Simon, G. M. & Cravatt, B. F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347\u20131356 (2007).","journal-title":"Chem. Biol."},{"key":"155_CR32","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1194\/jlr.M030411","volume":"53","author":"D Navia-Paldanius","year":"2012","unstructured":"Navia-Paldanius, D., Savinainen, J. R. & Laitinen, J. T. Biochemical and pharmacological characterization of human \u03b1\/\u03b2-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12). J. Lipid Res. 53, 2413\u20132424 (2012).","journal-title":"J. Lipid Res."},{"key":"155_CR33","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1073\/pnas.1222025110","volume":"110","author":"MB Oldstone","year":"2013","unstructured":"Oldstone, M. B. Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza. Proc. Natl Acad. Sci. USA 110, 4180\u20134183 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"155_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"155_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301\u20131309 (2006).","journal-title":"Nat. Med."},{"key":"155_CR36","doi-asserted-by":"publisher","first-page":"8925","DOI":"10.1073\/pnas.1408148111","volume":"111","author":"R Baccala","year":"2014","unstructured":"Baccala, R. et al. Type I interferon is a therapeutic target for virus-induced lethal vascular damage. Proc. Natl Acad. Sci. USA 111, 8925\u20138930 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"155_CR37","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20121015","volume":"209","author":"H Frebel","year":"2012","unstructured":"Frebel, H. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209, 2485\u20132499 (2012).","journal-title":"J. Exp. Med."},{"key":"155_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/jhg.2012.91","volume":"57","author":"B Rabbani","year":"2012","unstructured":"Rabbani, B., Mahdieh, N., Hosomichi, K., Nakaoka, H. & Inoue, I. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J. Hum. Genet. 57, 621\u2013632 (2012).","journal-title":"J. Hum. Genet."},{"key":"155_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat. Genet. 49, 1373\u20131384 (2017).","journal-title":"Nat. Genet."},{"key":"155_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar, A. et al. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177\u2013183 (2016).","journal-title":"Nature"},{"key":"155_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tips.2018.02.011","volume":"39","author":"M Alhouayek","year":"2018","unstructured":"Alhouayek, M., Masquelier, J. & Muccioli, G. G. Lysophosphatidylinositols, from cell membrane constituents to GPR55 ligands. Trends Pharmacol. Sci. 39, 586\u2013604 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"155_CR42","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson, J. K. & Miller, S. D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916\u20133924 (2004).","journal-title":"J. Immunol."},{"key":"155_CR43","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.4049\/jimmunol.1003600","volume":"186","author":"JJ Neher","year":"2011","unstructured":"Neher, J. J. et al. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J. Immunol. 186, 4973\u20134983 (2011).","journal-title":"J. Immunol."},{"key":"155_CR44","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4049\/jimmunol.177.1.583","volume":"177","author":"S Lehnardt","year":"2006","unstructured":"Lehnardt, S. et al. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2\/MyD88 pathway in microglia. J. Immunol. 177, 583\u2013592 (2006).","journal-title":"J. Immunol."},{"key":"155_CR45","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.4049\/jimmunol.178.10.6476","volume":"178","author":"O Hoffmann","year":"2007","unstructured":"Hoffmann, O. et al. TLR2 mediates neuroinflammation and neuronal damage. J. Immunol. 178, 6476\u20136481 (2007).","journal-title":"J. Immunol."},{"key":"155_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/lio2.28","volume":"1","author":"A Vambutas","year":"2016","unstructured":"Vambutas, A. & Pathak, S. AAO: autoimmune and autoinflammatory (disease) in otology: what is new in immune-mediated hearing loss. Laryngoscope Investig. Otolaryngol. 1, 110\u2013115 (2016).","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"155_CR47","first-page":"969657","volume":"2012","author":"B Wootla","year":"2012","unstructured":"Wootla, B., Eriguchi, M. & Rodriguez, M. Is multiple sclerosis an autoimmune disease? Autoimmune Dis. 2012, 969657 (2012).","journal-title":"Autoimmune Dis."},{"key":"155_CR48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/acsmedchemlett.8b00191","volume":"9","author":"RM Suciu","year":"2018","unstructured":"Suciu, R. M., Cognetta, A. B. III, Potter, Z. E. & Cravatt, B. F. Selective irreversible inhibitors of the Wnt-deacylating enzyme NOTUM developed by activity-based protein profiling. ACS Med. Chem. Lett. 9, 563\u2013568 (2018).","journal-title":"ACS Med. Chem. Lett."},{"key":"155_CR49","doi-asserted-by":"publisher","first-page":"20941","DOI":"10.1073\/pnas.1011663107","volume":"107","author":"DA Bachovchin","year":"2010","unstructured":"Bachovchin, D. A. et al. Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening. Proc. Natl Acad. Sci. USA 107, 20941\u201320946 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"155_CR50","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.chembiol.2005.08.011","volume":"12","author":"JP Alexander","year":"2005","unstructured":"Alexander, J. P. & Cravatt, B. F. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. Chem. Biol. 12, 1179\u20131187 (2005).","journal-title":"Chem. Biol."},{"key":"155_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nmeth.1769","volume":"9","author":"BR Martin","year":"2011","unstructured":"Martin, B. R., Wang, C., Adibekian, A., Tully, S. E. & Cravatt, B. F. Global profiling of dynamic protein palmitoylation. Nat. Methods 9, 84\u201389 (2011).","journal-title":"Nat. Methods"},{"key":"155_CR52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nmeth.2368","volume":"10","author":"JJ Hulce","year":"2013","unstructured":"Hulce, J. J., Cognetta, A. B., Niphakis, M. J., Tully, S. E. & Cravatt, B. F. Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells. Nat. Methods 10, 259\u2013264 (2013).","journal-title":"Nat. Methods"},{"key":"155_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1073\/pnas.1522364112","volume":"113","author":"D Ogasawara","year":"2016","unstructured":"Ogasawara, D. et al. Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition. Proc. Natl Acad. Sci. USA 113, 26\u201333 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"155_CR54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/JVI.69.2.1059-1070.1995","volume":"69","author":"P Borrow","year":"1995","unstructured":"Borrow, P., Evans, C. F. & Oldstone, M. B. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69, 1059\u20131070 (1995).","journal-title":"J. Virol."},{"key":"155_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.160.2.521","volume":"160","author":"R Ahmed","year":"1984","unstructured":"Ahmed, R., Salmi, A., Butler, L. D., Chiller, J. M. & Oldstone, M. B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521\u2013540 (1984).","journal-title":"J. Exp. Med."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0155-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0155-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0155-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:26:29Z","timestamp":1684621589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-018-0155-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1038\/s41589-018-0155-8","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.U. and A.R. are employees of and B.F.C. is a founder and advisor to Abide Therapeutics, a biotechnology company interested in developing serine hydrolase inhibitors and therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}